News

Gibson Energy Refreshes Share Repurchase Strategy to Benefit Investors

Gibson Energy Refreshes Share Repurchase Strategy to Benefit Investors

Gibson Energy Boosts Shareholder Value with NCIB Renewal

Gibson Energy Inc. is making a notable move to enhance shareholder value by renewing its Normal Course Issuer Bid (NCIB). This Toronto-based company, which is active in the liquids infrastructure sector, has received formal approval from its Board of Directors as well as the Toronto Stock Exchange (TSX) to extend its share repurchase program.

Insights on the Normal Course Issuer Bid

Starting on September 18, 2024, Gibson Energy will be able to buy back up to 7.5% of its public float, translating to roughly 9,958,026 common shares, over the following year. As of mid-September 2024, the company had 162,758,103 common shares outstanding. This repurchase plan is a deliberate action designed to maximize returns for its shareholders.

How Market Operations Work Under the NCIB

The NCIB allows shares to be bought back through open market transactions on the TSX as well as other approved Canadian trading platforms. A key component of this initiative is the daily purchase cap, which stands at 132,241 common shares. This limit is determined by assessing the average daily trading volume for the six months leading up to August 2024.

Strategic Share Price Management

According to the NCIB guidelines, repurchases will happen at market price. This ensures that Gibson Energy can make the most of its shares' value during the repurchase period. The company understands that smart use of its NCIB could strengthen its commitment to boosting shareholder wealth. While the previous NCIB allowed for the repurchase of 9,812,193 shares from September 2023 to September 2024, the company opted not to buy any shares during that time, demonstrating a cautious approach to share repurchases.

Modernizing the Shares Purchase Process

To simplify its purchasing efforts, Gibson Energy has established an automated purchase plan with its broker, BMO Nesbitt Burns Inc. This setup enables the company to conduct purchases even during regulatory limitations or blackout periods. As a result, Gibson can respond more proactively to market fluctuations and manage share repurchases efficiently, adhering to TSX regulations.

About Gibson Energy

As a prominent player in the liquids infrastructure sector, Gibson Energy focuses on the storage, optimization, and processing of liquids and refined products. With its headquarters in Calgary, Alberta, the company has built a significant presence across North America, featuring important terminal facilities in Hardisty and Edmonton, Alberta, along with locations in Ingleside, Texas, and Moose Jaw, Saskatchewan. Investors can trade the company’s shares under the symbol GEI on the Toronto Stock Exchange, providing them opportunities to engage with its growth strategies.

Gibson Energy's Commitment to Shareholders

Gibson Energy consistently highlights its commitment to making thoughtful decisions that boost shareholder value. Through this renewal of their NCIB, the company signals its intention to stay agile and responsive, adeptly navigating market demands while maintaining its focus on generating returns for its investors.

Frequently Asked Questions

What is the purpose of Gibson Energy's NCIB?

The NCIB enables Gibson Energy to buy back its shares, potentially increasing shareholder value by reducing the total number of shares in circulation.

How many shares can Gibson Energy repurchase under the new NCIB?

The company is allowed to buy back up to 9,958,026 shares, which is about 7.5% of its public float.

What is the daily purchase limit set for Gibson Energy's NCIB?

The daily purchase limit stands at 132,241 common shares, equivalent to 25% of the average daily trading volume over the past six months.

What factors influence Gibson’s decisions regarding share repurchases?

Decisions are made based on market conditions, share price, financial strategy, and adherence to its financial governance principles.

What automated processes have been set up for buying back shares?

Gibson has implemented an automatic purchase plan with BMO Nesbitt Burns Inc., enabling it to buy back shares even during regulatory restrictions that would normally apply.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 36

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 26

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 36

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 41

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 36

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 32

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 4

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading

Top 5 Most Recently Viewed Articles

AgEagle Aerial Systems Welcomes Kevin Lowdermilk to the Board

Updated Category News Views 103

AgEagle Aerial Systems Welcomes Kevin Lowdermilk to the Board AgEagle Aerial Systems Inc. (NYSE: UAVS), renowned for its top-tier unmanned aerial systems (UAS), is excited to announce the recent addition of Kevin Lowdermilk to its board of directors. His appointment, effective as of late October, marks a strategic enhancement to the company's leadership team, ensuring...

Continue Reading
Natera's Growth Continues Amid Legal Challenges and Market Wins

Updated Category News Views 413

Natera Faces Legal Challenges with Strong Market Performance Natera, Inc. (NASDAQ: NTRA) is a leader in the genetic testing industry, known for its groundbreaking contributions to oncology and women’s health. Recently, the company encountered an unfavorable jury decision in a legal battle concerning false advertising claims made against Guardant Health (NASDAQ: GH). The...

Continue Reading
Spreedly Sees Unprecedented Growth in Open Payments Sector

Updated Category News Views 110

Spreedly Surges Ahead in Open Payments Innovation Spreedly, a prominent leader in open payments, has recently showcased remarkable progress in revenue and customer expansion, marking a new chapter in the payment processing industry. With a growing clientele that spans across varied sectors, the company is redefining how digital transactions are handled worldwide. Key...

Continue Reading
Shelley Joyce Takes the Helm as CTO at TSG, Ramping Up Innovation

Updated Category News Views 431

TSG Appoints Shelley Joyce as New Chief Technology Officer In a significant move to enhance its technology initiatives, TSG (The Strawhecker Group) has announced the appointment of Shelley Joyce as the Chief Technology Officer (CTO). With her extensive background in the payments industry, Shelley is set to lead TSG’s technological advancements and cater to the evolving...

Continue Reading
Equillium Plans Engaging Event for Ulcerative Colitis Insights

Updated Category News Views 121

Equillium's Upcoming Event on Ulcerative Colitis Equillium, Inc. (NASDAQ: EQ), a biotechnology company focused on developing innovative therapeutics for autoimmune and inflammatory diseases, has announced an exciting virtual event featuring prominent thought leaders in the field of ulcerative colitis (UC). This event is scheduled for a Wednesday in November at 12 PM ET....

Continue Reading